Recorded Presentation from the NCCN Pharmacy Updates: Novel Agents for the Treatment of Relapsed/Refractory Multiple Myeloma
Several new options have recently been approved for the treatment of relapsed/refractory multiple myeloma. Pharmacists should be aware of the new data and recommendations surrounding these novel agents and how they relate to improvements in patient survival and quality of life.
Category
  • Multiple Myeloma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: Emerging Strategies for Pediatric Hodgkin Lymphoma Treatment
It is important for pharmacists to understand the long-term side effects of both systemic treatment and radiation in order to provide in-depth patient counseling, as well as appropriate therapy recommendations to the multidisciplinary team.
Category
  • Hodgkin Lymphoma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: Understanding the Molecular Heterogeneity of Diffuse Large B-Cell Lymphomas and the Place of Targeted Therapies in Treatment
New promising combinations of chemoimmunotherapy with antibody drug conjugates, and small molecule inhibitors may offer an alternative approach for patients with relapsed or refractory disease. Many of these new therapies are oral and will be managed by a multidisciplinary team.
Category
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: Palliative Care for Patients with Cancer - Symptom Management for Pain and Dyspnea
Pharmacists can play a critical role in patient education, therapy recommendations, and therapy management in palliative care and should be familiar with appropriate pharmacologic interventions for symptom management.
Category
  • Palliative Care
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: Best Practices for Transitioning Oncology Therapies from the Inpatient to the Outpatient Setting
It is important for pharmacists to be familiar with the steps that are involved in transitioning oncology therapies that have been historically provided in an inpatient setting to the outpatient setting, and be familiar with the criteria for successful implementation of such an initiative.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Case 1: Newly Diagnosed CLL/SLL without del(17p)/TP53 mutation in a patient
Earn CME/CE while testing your knowledge. Try your skills at this challenging case in CLL/SLL.
Category
  • Chronic Lymphocytic Leukemia
Format
  • Enduring Activity
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Case 2: Newly Diagnosed CLL/SLL with del(17p)/TP53 mutation
Earn CME/CE while testing your knowledge. Try your skills at this challenging case in CLL/SLL.
Category
  • Chronic Lymphocytic Leukemia
Format
  • Enduring Activity
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Case 3: Relapsed CLL/SLL without del(17p)/TP53 mutation in a patient ≥65 years
Earn CME/CE while testing your knowledge. Try your skills at this challenging case in CLL/SLL.
Category
  • Chronic Lymphocytic Leukemia
Format
  • Enduring Activity
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Case 4: Relapsed CLL/SLL with del(17p)/TP53 mutation and ibrutinib intolerance in a patient ≥65 years
Earn CME/CE while testing your knowledge. Try your skills at this challenging case in CLL/SLL.
Category
  • Chronic Lymphocytic Leukemia
Format
  • Enduring Activity
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: Advances in the Management of Gastrointestinal Stromal Tumors (GIST) and Other Soft Tissue Sarcomas
Continued education for oncology care providers is necessary to convey updates in the management of STS and improve patient outcomes.
Category
  • Soft Tissue Sarcomas
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation

Pages